Protaryx Medical raises $8.3m

Protaryx Medical announced today that it raised $8.3 million for the development of its first-in-class device for transseptal access to the left atrium.

The Baltimore-based company’s funding includes non-dilutive grants and a seed round totaling $3.2 million, along with a recently closed $5.1 million Series A round led by Ajax Health, with participation from returning investor University of Maryland Ventures.

Protaryx’s device is designed for use in catheter-based procedures, including mitral valve repair and replacement, left atrial appendage closure and catheter ablation to treat cardiac arrhythmias, according to a news release.

The company designed the system to give physicians confidence in accuracy and safety during procedures through independent steerability and three-dimensional control, streamlining rapid crossing to the left heart. Currently, the Protaryx device is not commercially available anywhere.

“There is currently an op…

Read more
  • 0